IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on February 5, 2016. The filing serves to announce the Company's financial results for the fourth quarter ended December 31, 2015. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing does not explicitly state material changes versus the prior comparable period within the body text. It directs readers to the press release for the announcement of results.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that Section. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 5, 2016) for specific Q4 2015 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any forward-looking statements or guidance updates in the attached exhibit.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial announcement.